CDH1 and ovarian carcinoma: Intriguingly, various studies in prostate (Dhingra et al., 2017), breast (Ma et al., 2010) and ovarian cancer (Zhou et al., 2017) have shown that overexpression of miR‐9 correlated with decreased E‐cadherin expression.